Alhomoud, M., Perales, M., Nemirovsky, D., Heller, G., Lin, A., Dahi, P., Walji, M., Shah, G., Politikos, I., Hughes, C., Raju, G., Lin, R., Jakubowski, A., Papadopoulos, E., Ponce, D., Sauter, C., Tamari, R., Giralt, S., Shaffer, B., Scordo, M. (2025). Fludarabine pharmacokinetic model identifies an optimal exposure associated with improved outcomes in allogeneic hematopoietic cell transplantation recipients receiving post-transplant cyclophosphamide. Blood. https://doi.org/10.1182/blood-2025-113